{"url_path":"/sec/nndm/8-k/2026-06-15/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-15","source_url":"https://www.sec.gov/Archives/edgar/data/1643303/0001104659-26-073776-index.html","accession_number":"0001104659-26-073776","cik":"0001643303","ticker":"NNDM","issuer_name":"Nano Dimension Ltd.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1643303/0001104659-26-073776-index.html","primary_entity_key":"0001643303","primary_entity_name":"Nano Dimension Ltd."},"word_count":127,"has_tables":true,"body_markdown":"**Item 9.01.**\n**Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits\n\n \n\n**Exhibit**\n\n**No.**\n\n \n**Description**\n\n[99.1](tm2617934d1_ex99-1.htm)\n \n[Non-Binding Term Sheet, dated June 15, 2026, by and between Nano Dimension Ltd. and Infinite Epigenetics,\nInc.](tm2617934d1_ex99-1.htm)\n\n \n \n\n[99.2](tm2617934d1_ex99-2.htm)\n \n[Press Release issued by the Company on June 15, 2026.](tm2617934d1_ex99-2.htm)\n\n \n \n \n\n[99.3](tm2617934d1_ex99-3.htm)\n \n[Investor Presentation dated June 15, 2026.](tm2617934d1_ex99-3.htm)\n\n \n \n \n\n[99.4](tm2617934d1_ex99-4.htm)\n \n[Transcript of Conference Call and Webcast held by Nano Dimension Ltd. and Infinite Epigenetics,\nInc. on June 15, 2026.](tm2617934d1_ex99-4.htm)\n\n \n \n \n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n** **\n\n**SIGNATURES**\n\n** **\n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n**Nano Dimension Ltd.\n(Registrant)**\n\n \n \n \n\nDate:\nJune 15, 2026\nBy:\n/s/ John Brenton\n\n \n \nJohn\nBrenton\n\n \n \nChief\nFinancial Officer"}